Therefore, more well-designed RCTs following the CONSORT statement are required to be more confidant in the results obtained on PCOS women during fresh cycles and to further compare the effects of the Conventional GnRH antagonist protocols and the GnRH agonist protocols on IVF/ICSI outcomes during frozen ones. This evidence concerns the gene GNRH1 and polycystic ovary syndrome.